Nivolumab with or without Relatlimab in Untreated Advanced Melanoma. Reply
- PMID: 35544394
- DOI: 10.1056/NEJMc2201558
Nivolumab with or without Relatlimab in Untreated Advanced Melanoma. Reply
Comment on
-
Nivolumab with or without Relatlimab in Untreated Advanced Melanoma.N Engl J Med. 2022 May 12;386(19):1860. doi: 10.1056/NEJMc2201558. N Engl J Med. 2022. PMID: 35544393 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical